ONX-0914 (PR-957) PR-957
ONX-0914 (PR-957)是一种有效的,选择性immunoproteasome抑制剂,无细胞试验中对组成型蛋白酶体具有最低的交叉反应性。
-
货号:
TK0522 -
规格:
- 5mg
- 10mg
- 50mg
-
价格:
¥0.00
ONX-0914 (PR-957)是一种有效的,选择性immunoproteasome抑制剂,无细胞试验中对组成型蛋白酶体具有最低的交叉反应性。
| CAS No. | 960374-59-8 |
| 生物活性 | ONX-0914 (PR-957) is a selective inhibitor of low-molecular mass polypeptide-7 (LMP7), the chymotrypsin-like subunit of the immunoproteasome. ONX-0914 blocks cytokine production and attenuates progression of experimental arthritis. ONX-0914 is a noncompetitive irreversible inhibitor of the mycobacterial proteasome (Ki=5.2 μM). ONX-0914 reactivates latent HIV-1 through p-TEFb activation mediated by HSF-1. |
| 分子式 | C31H40N4O7 |
| 分子量 | 580.67 |
| 运输条件 | Room temperature in continental US; may vary elsewhere. |
| 储存条件 | Powder, -20°C ,3 years |
| 溶解性数据 | DMSO : ≥ 35 mg/mL (60.28 mM) |
| 体内研究 | ONX-0914 (2-10 mg/kg; i.v,; on days 4, 6 and 8) meliorates disease in mouse arthritis.ONX-0914 (2, 6 and 10 mg per kg body weight on days 25, 27, 29, 31 and 33; i.v.) treatment also induced a rapid therapeutic response in the T and B cell–dependent CIA (collagen-induced arthritis) model. |
| 体外研究 | ONX-0914 inhibits LMP7-specific antigen presentation. ONX-0914 blocks cytokine productionby mouse splenocytes and blocks T celldifferentiation. |
| 纯度及产品资料 | 98% |